Anika Therapeutics (ANIK) Deferred Taxes (2010 - 2026)
Anika Therapeutics (ANIK) reported Deferred Taxes of $108000.0 for Q1 2026, up 500.0% year-over-year from $18000.0 in Q1 2025, and up 532.0% quarter-over-quarter from -$25000.0 in Q4 2025.
Anika Therapeutics (ANIK) Deferred Taxes (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has 16 years of Deferred Taxes data on file, last reported at $108000.0 in Q1 2026.
- Deferred Taxes for Q1 2026 came in at $108000.0, up 500.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $83000.0 (down 2.35% YoY), and the FY2025 annual result was -$7000.0, down 102.69% from the prior year.
- Deferred Taxes improved to $108000.0 in Q1 2026 per ANIK's latest filing, from -$25000.0 in the prior quarter.
- Over five years, Deferred Taxes peaked at $234000.0 in Q4 2024 and troughed at -$2.4 million in Q1 2023.
- A 5-year average of -$660941.2 and a median of -$184000.0 in 2024 frame the typical range for Deferred Taxes.
- The sharpest annual moves came in 2023 and 2026: Deferred Taxes plunged 769.23% in 2023, then surged 500.0% in 2026.
- A 5-year view of Deferred Taxes shows it stood at -$1.8 million in 2022, then declined by 3.6% to -$1.8 million in 2023, then jumped by 112.7% to $234000.0 in 2024, then tumbled by 110.68% to -$25000.0 in 2025, then jumped by 532.0% to $108000.0 in 2026.
- Business Quant data shows ANIK's Deferred Taxes at $108000.0 in Q1 2026, -$25000.0 in Q4 2025, and $3000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -22.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 34.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 25.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 14,341.73 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -61.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -8.79 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -13.98 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 19.33 Mn |
| 10 | Anika Therapeutics | 197.89 Mn | 131.10 Mn | 19.00 Mn | 108,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108,000.00 |
| Dec 31, 2025 | -25,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Dec 31, 2024 | 234,000.00 |
| Sep 30, 2024 | -184,000.00 |
| Jun 30, 2024 | 17,000.00 |
| Mar 31, 2024 | 193,000.00 |
| Dec 31, 2023 | -1.84 Mn |
| Sep 30, 2023 | -1.21 Mn |
| Jun 30, 2023 | -904,000.00 |
| Mar 31, 2023 | -2.37 Mn |
| Dec 31, 2022 | -1.78 Mn |
| Sep 30, 2022 | -1.47 Mn |
| Jun 30, 2022 | -1.75 Mn |
| Mar 31, 2022 | -273,000.00 |
| Dec 31, 2021 | -2.78 Mn |
| Sep 30, 2021 | -178,000.00 |
| Jun 30, 2021 | 2.36 Mn |